Article Text

Download PDFPDF
Idoxuridine: an antiviral drug for ocular herpes simplex


Because thymidine and deoxycytidine are essential components of desoxyribonucleic acid (DNA), these and similar substances have been modified to produce antimetabolites for the treatment of cancer, and experimentally against tumour-producing viruses. One modification, idoxuridine (Kerecid - SKF), is offered for the treatment of herpes simplex keratitis, of which the commonest form is dendritic ulcer. The drug does not kill the virus, but it does interfere with its multiplication. Strains of virus resistant to idoxuridine have been observed in experimental studies; whether these are important clinically is not known.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * Based on material published on December 20, 1963 in The Medical Letter, New York